Feng Wei

929 total citations
37 papers, 567 citations indexed

About

Feng Wei is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Feng Wei has authored 37 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 12 papers in Cancer Research and 11 papers in Immunology. Recurrent topics in Feng Wei's work include Immune Response and Inflammation (6 papers), MicroRNA in disease regulation (4 papers) and Virus-based gene therapy research (3 papers). Feng Wei is often cited by papers focused on Immune Response and Inflammation (6 papers), MicroRNA in disease regulation (4 papers) and Virus-based gene therapy research (3 papers). Feng Wei collaborates with scholars based in China, United States and Japan. Feng Wei's co-authors include Xiaodan Jiang, Zhuoya Li, Bingjiao Yin, Lin Wan, Guohong Lin, Dongya Zhang, Xiaoyan Li, Zhihai Qin, Jing Wang and Xin Hu and has published in prestigious journals such as The Journal of Immunology, Biological Psychiatry and Molecular Ecology.

In The Last Decade

Feng Wei

34 papers receiving 560 citations

Peers

Feng Wei

IMMUN

ONCOL

EPIDE

Silvana Caristi Italy

Amr Al‐Haidari Sweden

Daisuke Ohshima Japan

Patrycja Przygodzka Poland

Catherine Olesch Germany

Ivan Scudiero Italy

Péter Pócza Hungary

Anani Aila Mat Zin Malaysia

Stéphane Jemelin Switzerland

Justina McEvoy United States

Silvana Caristi Italy

Feng Wei

215 ×0.8

IMMUN

221 ×0.9

96 ×0.7

136 ×1.2

ONCOL

18 ×0.6

EPIDE

Citations per year, relative to Feng Wei Feng Wei (= 1×) peers Silvana Caristi

Countries citing papers authored by Feng Wei

Since Specialization

Citations

This map shows the geographic impact of Feng Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Wei more than expected).

Fields of papers citing papers by Feng Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Wei. The network helps show where Feng Wei may publish in the future.

Co-authorship network of co-authors of Feng Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Wei. A scholar is included among the top collaborators of Feng Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Wei. Feng Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sun, Zewen, Dandan Wang, Guoxin Li, et al.. (2025). Integrative multi-omics analysis decodes HOXC9-driven malignant transformation and metastasis in OSCC. iScience. 28(9). 112919–112919.

Luo, Lili, Feng Wei, Mei Mei, et al.. (2024). Greater variability in HDL-C was associated with an increased risk of cognitive decline in the middle- and elderly Chinese: A cohort study. Archives of Gerontology and Geriatrics. 125. 105503–105503. 4 indexed citations

Ma, Xiaona, Shiow‐Ing Wang, Feng Wei, et al.. (2024). Risk of dyslipidemia and major adverse cardiac events with tofacitinib versus adalimumab in rheumatoid arthritis: a real-world cohort study from 7580 patients. Frontiers in Pharmacology. 15. 1370661–1370661. 8 indexed citations

Ma, Xiaona, et al.. (2024). Methotrexate and the Risk of Dementia: A Two-Sample Mendelian Randomization Study. Neurology and Therapy. 13(3). 715–725. 2 indexed citations

Wei, Feng, Shuo Wang, Kaiyue Zhang, et al.. (2024). Exploration the mechanism underlying protocatechuic acid in treating osteoporosis by HIF-1 pathway based on network pharmacology, molecular docking, molecular dynamics simulation and experimental verification. Journal of Functional Foods. 122. 106531–106531. 1 indexed citations

Zhang, Lihua, Hui Guo, Xiaoguang Zhang, et al.. (2024). Small nucleolar RNA Snora73 promotes psoriasis progression by sponging miR-3074-5p and regulating PBX1 expression. Functional & Integrative Genomics. 24(1). 15–15. 3 indexed citations

Lan, Chuan, Yo‐ichi Yamashita, Hiromitsu Hayashi, et al.. (2022). High Expression of Bloom Syndrome Helicase is a Key Factor for Poor Prognosis and Advanced Malignancy in Patients with Pancreatic Cancer: A Retrospective Study. Annals of Surgical Oncology. 29(6). 3551–3564. 3 indexed citations

Fu, Lingfeng, Atsuko Yonemura, Noriko Yasuda‐Yoshihara, et al.. (2022). Intracellular MUC20 variant 2 maintains mitochondrial calcium homeostasis and enhances drug resistance in gastric cancer. Gastric Cancer. 25(3). 542–557. 20 indexed citations

Zhang, Jun, Lingfeng Fu, Noriko Yasuda‐Yoshihara, et al.. (2022). IL-1β derived from mixed-polarized macrophages activates fibroblasts and synergistically forms a cancer-promoting microenvironment. Gastric Cancer. 26(2). 187–202. 15 indexed citations

10.

Wei, Feng, Dongya Zhang, & Ruitao Zhang. (2021). Circ-ABCB10 knockdown inhibits the malignant progression of cervical cancer through microRNA-128-3p/ZEB1 axis. Biological Procedures Online. 23(1). 17–17. 15 indexed citations

11.

Xu, Wei, Feng Wei, Xue‐Ning Shen, et al.. (2020). Amyloid Pathologies Modulate the Associations of Minimal Depressive Symptoms With Cognitive Impairments in Older Adults Without Dementia. Biological Psychiatry. 89(8). 766–775. 19 indexed citations

12.

Zhang, Dongya, et al.. (2019). LAMC2 regulated by microRNA-125a-5p accelerates the progression of ovarian cancer via activating p38 MAPK signalling. Life Sciences. 232. 116648–116648. 25 indexed citations

13.

Wei, Feng, Xianling Guo, Haidong Huang, et al.. (2018). Polymorphism rs3819102 in thymidylate synthase and environmental factors: effects on lung cancer in Chinese population. Current Problems in Cancer. 43(1). 66–74. 6 indexed citations

14.

Zhang, Ruitao, Huirong Shi, Fang Ren, et al.. (2016). Knockdown of MACC1 expression increases cisplatin sensitivity in cisplatin-resistant epithelial ovarian cancer cells. Oncology Reports. 35(4). 2466–2472. 18 indexed citations

15.

Zhang, Shu, Tao Liu, Huifang Liang, et al.. (2009). Lipid rafts uncouple surface expression of transmembrane TNF-α from its cytotoxicity associated with ICAM-1 clustering in Raji cells. Molecular Immunology. 46(7). 1551–1560. 20 indexed citations

16.

Yu, Mingxia, Wenfang Shi, Jian Zhang, et al.. (2008). Influence of reverse signaling via membrane TNF-α on cytotoxicity of NK92 cells. European Journal of Cell Biology. 88(3). 181–191. 27 indexed citations

17.

Yan, Dan, Nalin Qin, Hailong Zhang, et al.. (2008). Expression of TNF-α leader sequence renders MCF-7 tumor cells resistant to the cytotoxicity of soluble TNF-α. Breast Cancer Research and Treatment. 116(1). 91–102. 24 indexed citations

18.

Xing, Yifei, Yajun Xiao, Fuqing Zeng, et al.. (2007). Altered expression of connexin-43 and impaired capacity of gap junctional intercellular communication in prostate cancer cells. Journal of Huazhong University of Science and Technology [Medical Sciences]. 27(3). 291–294. 11 indexed citations

19.

Huang, Baojun, Hui Yin, Yafei Huang, et al.. (2006). Gene therapy using adenoviral vector encoding 4-1BBIg gene significantly prolonged murine cardiac allograft survival. Transplant Immunology. 16(2). 88–94. 17 indexed citations

20.

Zheng, Fang, Feili Gong, Zhuoya Li, et al.. (2002). Mutational analysis of region-cytotoxicity relationship in human transmembrane tumor necrosis factor-alpha. The Chinese-German Journal of Clinical Oncology. 1(1). 38–41. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact